BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 36 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 36 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT

Crawford & Company (CRD-A) Earnings: 4Q22 Key Numbers

Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $322.2 million for the fourth quarter of 2022, up 10% year-over-year. Net loss attributable to shareholders was $14.1 million, or $0.29 per share, compared to net income of $1.7 million, or $0.03 per share, last year. Adjusted EPS was $0.23. Consolidated cash and cash equivalents […]

March 7, 2023 1 min read

Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $322.2 million for the fourth quarter of 2022, up 10% year-over-year.

Net loss attributable to shareholders was $14.1 million, or $0.29 per share, compared to net income of $1.7 million, or $0.03 per share, last year. Adjusted EPS was $0.23.

Consolidated cash and cash equivalents as of December 31, 2022, were $46 million.

ADVERTISEMENT